Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

QMN: New Market Neutral ETF from Index IQ

QMN: New Market Neutral ETF from Index IQIndex IQ added to its lineup of hedge fund replication ETFs on October 4, 2012 with the launch of IQ Hedge Market Neutral Tracker ETF (NYSEARCA:QMN).  The new ETF seeks to track, before fees and expenses, the performance of the firm’s own IQ Hedge Market Neutral Index.  QMN does not invest in hedge funds.  Instead, it attempts to mimic the performance characteristics of market neutral hedge funds using a fund-of-funds approach with other ETFs.

Market neutral hedge funds typically invest in both long and short positions in multiple asset classes while minimizing exposure to systematic risk.  These strategies seek to have zero “beta” exposure to one or more systematic risk factors, which could include the overall stock market, economic sectors or industries, market cap, region, or country.  In theory, market neutral strategies that effectively neutralize market exposure are not impacted by directional moves in the market.

Top fund holdings include Vanguard Short-Term Bond (NYSEARCA:BSV) 26.0%, iShares Barclays 1-3 Year Treasry Bnd Fd (NYSEARCA:SHY) 25.1%, iShares MSCI EAFE Index Fund (NYSEARCA:EFA) 8.2%, Vanguard Total Bond Market (NYSEARCA:BND) 8.2%, iShares Barclays Short Treasury Bond Fnd (NYSEARCA:SHV) 7.8%, SPDR Barclays Capital Convertible Sec (NYSEARCA:CWB) 7.5%, and iShares Barclays Aggregate Bond Fund (NYSEARCA:AGG) 7.4%.

The net expense ratio will vary over time based on the fees of the ETFs in QMN’s portfolio.  The current expense ratio of 0.99% has 0.24% designated as acquired fund expenses.  Additional information can be found on the overview page and in the prospectus (pdf).

Analysis/Opinion: The underlying index has 1-year and 3-year performance figures of 5.25% and 4.03% annually as of 9/30/12.  Assuming perfect tracking, the fund’s theoretical returns would have been 4.5% and 3.3%.  These are less than the iShares Barclays Aggregate Bond (AGG) returns of 5.0% and 5.7%.  No risk data for the underlying index could be found.  If you choose to compare these returns to stocks, the SPDR S&P 500 Trust(NYSEARCA:SPY) returns for the same periods were 30.1% and 13.1%.

Rather than taking a long/short approach to market neutrality, the underlying index attempts to mimic market neutral characteristics by investing primarily in bond ETFs at this time.  The only inverse equity exposure for the index consists of a 1.0% allocation to ProShares UltraShort Russell2000 (NYSEARCA:TWM).

Far from being market neutral, the current asset class exposures are Bonds 77.0% (84.2% if convertibles are included), Equities 11.0%, Hybrids 7.2%, and Currencies 3.0%.  There are about 35 products listed in the Alternative Strategy section of the ETF Field Guide.  For the most part, their performance has been underwhelming.  However, a full market cycle is necessary for a more objective analysis.

This article was originally written by Ron Rowland, and posted on InvestWithAnEdge.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.